Northstar Advisory Group LLC Purchases 2,117 Shares of McKesson Corporation $MCK

Key Points

• Northstar Advisory Group LLC increased its stake in McKesson by 133.4% in Q4, buying 2,117 shares to hold 3,704 shares valued at about $3.04 million.
• McKesson beat quarterly expectations with EPS of $9.34 (vs. $9.19 est.) and revenue of $106.16 billion, and set FY2026 guidance of 38.800–39.200 EPS while analysts forecast ~32.77 EPS for the current year.
• The company announced a quarterly dividend of $0.82 (annualized $3.28, ~0.4% yield) and carries a consensus Moderate Buy analyst rating with an average price target of $960.93 (JPMorgan raised its target to $1,107).

Northstar Advisory Group LLC increased its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 133.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,704 shares of the company's stock after buying an additional 2,117 shares during the quarter. Northstar Advisory Group LLC's holdings in McKesson were worth $3,038,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of McKesson by 0.9% during the third quarter. State Street Corp now owns 5,750,519 shares of the company's stock valued at $4,447,110,000 after acquiring an additional 51,510 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of McKesson by 3.5% in the 3rd quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock worth $2,071,428,000 after purchasing an additional 90,948 shares in the last quarter. Alliancebernstein L.P. grew its position in McKesson by 5.6% in the 3rd quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock valued at $1,850,001,000 after purchasing an additional 126,684 shares during the period. Northern Trust Corp grew its position in McKesson by 0.4% in the 3rd quarter. Northern Trust Corp now owns 1,532,856 shares of the company's stock valued at $1,184,193,000 after purchasing an additional 6,613 shares during the period. Finally, Boston Partners increased its stake in McKesson by 6.7% during the 3rd quarter. Boston Partners now owns 1,330,953 shares of the company's stock valued at $1,027,569,000 after purchasing an additional 83,357 shares in the last quarter. Institutional investors own 85.07% of the company's stock.

McKesson Price Performance

MCK opened at $860.37 on Tuesday. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a market capitalization of $105.39 billion, a price-to-earnings ratio of 24.74, a P/E/G ratio of 1.38 and a beta of 0.38. The firm's fifty day moving average price is $908.02 and its two-hundred day moving average price is $841.69.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period last year, the firm earned $8.03 earnings per share. The firm's revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's dividend payout ratio (DPR) is currently 9.43%.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Robert W. Baird set a $968.00 price objective on shares of McKesson in a research note on Wednesday, January 14th. Wall Street Zen raised shares of McKesson from a "hold" rating to a "buy" rating in a research report on Sunday, March 22nd. Raymond James Financial set a $970.00 price target on shares of McKesson in a research report on Thursday, March 5th. Evercore reiterated an "outperform" rating on shares of McKesson in a research note on Thursday, March 5th. Finally, JPMorgan Chase & Co. boosted their price objective on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a report on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $960.93.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. The trade was a 45.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by insiders.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.